Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. C-Rad AB (publ)
  6. Summary
    CRAD B   SE0002016352

C-RAD AB (PUBL)

(CRAD B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
60.9(c) 60.5(c) 63.2(c) 62.6(c) 61.6(c) Last
39 544 47 616 117 732 384 368 88 752 Volume
+2.01% -0.66% +4.46% -0.95% -1.60% Change
More quotes
Estimated financial data (e)
Sales 2021 267 M 31,1 M 31,1 M
Net income 2021 25,4 M 2,96 M 2,96 M
Net cash position 2021 134 M 15,6 M 15,6 M
P/E ratio 2021 82,2x
Yield 2021 -
Sales 2022 313 M 36,4 M 36,4 M
Net income 2022 41,5 M 4,82 M 4,82 M
Net cash position 2022 171 M 19,9 M 19,9 M
P/E ratio 2022 50,2x
Yield 2022 -
Capitalization 2 079 M 242 M 242 M
EV / Sales 2021 7,28x
EV / Sales 2022 6,09x
Nbr of Employees 55
Free-Float 66,7%
More Financials
Company
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the... 
Read more
More about the company
All news about C-RAD AB (PUBL)
07/26REMINDER : C-RAD Web Presentation Half-Year Report 2021
AQ
07/23C RAD : Former employee appeals verdict from the Stockholm Patent and Market cou..
AQ
07/20C RAD : announces that the South Florida Proton Therapy Institute has treated it..
AQ
07/15C RAD : Web Presentation Half-Year Report 2021
AQ
07/01C RAD : Patent and Market court resolution of claims made by former employee
AQ
06/23C RAD : strengthens its presence in India and South Asia
AQ
05/21C RAD : strengthens its management team
AQ
05/21C-RAD Announces Management Appointments
CI
05/07C RAD : 2021 opens with growth and improved profitability
AQ
05/04REMINDER : C-RAD Web Presentation Interim Report Q1 2021 and AGM speech
AQ
04/23C RAD : The Patent and Market Court of Appeal issues judgement confirming C-RAD'..
AQ
04/23C RAD : Web Presentation Interim Report Q1 2021 and AGM speech
AQ
02/22C RAD : Alliance radiation oncology at Anna Jaques hospital becomes a C-RAD tota..
AQ
02/22C-RAD and Alliance Radiation Oncology Announce That Alliance Has Become the F..
CI
02/03C RAD : and WITH-GLOBAL engage in a partnership for the South Korean market
AQ
More news
News in other languages on C-RAD AB (PUBL)

- No features available -

More news
Chart C-RAD AB (PUBL)
Duration : Period :
C-Rad AB (publ) Technical Analysis Chart | CRAD B | SE0002016352 | MarketScreener
Technical analysis trends C-RAD AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Last Close Price 61,60 SEK
Average target price 70,50 SEK
Spread / Average Target 14,4%
EPS Revisions
Managers and Directors
Tim Thurn President & Chief Executive Officer
Henrik Bergentoft Chief Financial Officer
Lars Gunnar Nyberg Chairman
Hakan Axelsson Chief Operating Officer
Kicki Wallje-Lund Independent Director
Sector and Competitors
1st jan.Capi. (M$)
C-RAD AB (PUBL)29.88%247
DANAHER CORPORATION33.98%212 478
THERMO FISHER SCIENTIFIC13.42%209 786
INTUITIVE SURGICAL, INC.19.97%116 550
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-8.37%80 274
SIEMENS HEALTHINEERS AG31.63%73 760